Treatment with ASIV reduced anti-inflammatory cytokines such as TGF-β, IL-10, and VEGF-A, while pro-inflammatory cytokines such as IFN-γ, IL-12, and TNF-α were increased in tumor tissue. The gene discussed is VEGFA; the disease is neoplasm.